Streetbeat News

Regulatory

NVIV

Trading for NVIV was halted and then resumed at 8:25 AM ET, following an update on its status. This event indicates a significant occurrence that prompted the halt and resumption, which could be due to a variety of reasons such as financial disclosures, regulatory news, or other material events.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 1:25 pm

BTCUSD

ETHUSD

Cryptocurrencies like Bitcoin, Ethereum, and Dogecoin fell after the Fed left rates unchanged, signaling a temporary setback. Meanwhile, a new ETF allows investment in major tech stocks, and Binance faces a lawsuit for allegedly aiding terrorists. In the US, market sentiment declined following the Fed's decision, impacting stocks and the Dow. Globally, tensions with Iran and China's cyber activities raise concerns. Economic indicators suggest a looming recession, while in tech, Apple's new products and partnerships draw attention. The electric vehicle sector sees advancements and legal challenges for Tesla.

Portfolio Pulse from Akanksha Bakshi

February 01, 2024 | 1:22 pm

BABA

NVDA

SOXL

Nvidia Corp (NASDAQ:NVDA) stock is up amid pre-orders for its new AI chip, the H20, for the Chinese market, competing with Huawei. Despite being less powerful than other Nvidia chips and Huawei's Ascend 910B, the H20 is priced between $12,000 and $15,000. Nvidia aims to maintain its presence in China, facing domestic competition and U.S. sanctions. Reports suggest Chinese cloud companies like Alibaba (NYSE:BABA) may reduce orders for high-end AI chips from Nvidia by 50%-60% within five years. Nvidia's stock gained 194% last year, with an 8% exposure to Direxion Daily Semiconductor Bull 3x Shares (NYSE:SOXL).

Portfolio Pulse from Anusuya Lahiri

February 01, 2024 | 1:19 pm

TNXP

Tonix Pharmaceuticals announced the results of its second Phase 3 trial for its fibromyalgia treatment candidate, TNX-102. The company plans to file for FDA approval based on these results.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 1:13 pm

GEHC

GE HealthCare has received 510(k) clearance from the FDA for its Novii+ Wireless Patch Solution, marking a significant regulatory approval that could enhance the company's product offerings in the healthcare sector.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 1:02 pm

NRBO

NeuroBo Pharmaceuticals has received FDA clearance for its Investigational New Drug (IND) application, allowing it to proceed with a Phase 1 clinical trial of DA-1726, a drug aimed at treating obesity. This marks a significant step forward in the company's development pipeline and could potentially address a major health issue globally.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 1:02 pm

ABEO

Abeona Therapeutics announced progress on its Pz-cel Biologics License Application, stating it remains on track for the PDUFA target action date of May 25, 2024. A BIMO inspection at Abeona's headquarters found no issues, and the FDA does not plan to convene an Advisory Committee for pz-cel.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 12:35 pm

AAPL

AMZN

META

QQQ

SPY

Nasdaq futures rebounded as traders anticipate strong earnings from tech giants Meta, Amazon, and Apple. The market reacted negatively to disappointing earnings from Alphabet, Microsoft, and AMD, and a hawkish Fed stance. The S&P 500 and Nasdaq Composite hit two-week lows. Analysts highlight the 'January Barometer' predicting a positive market trend for the year. SPDR S&P 500 ETF Trust and Invesco QQQ ETF saw premarket gains. Several companies, including Qorvo and Lucid Group, showed significant premarket movements.

Portfolio Pulse from Shanthi Rexaline

February 01, 2024 | 12:27 pm

EIS

SPY

USO

Reuters reported that OPEC+ will review in early March the possibility of extending the 2.2 million barrels per day (B/D) of voluntary oil production cuts, which are set to expire at the end of Q1. This decision is based on a source's information.

Portfolio Pulse from Charles Gross

February 01, 2024 | 12:17 pm

DIA

GLD

QQQ

SPY

Following the Federal Reserve's decision to keep interest rates unchanged at 5.25%-5.50%, U.S. stock markets closed lower, impacting global markets. The Dow Jones, S&P 500, and Nasdaq saw declines, with communication services and technology sectors hit hardest. Asian and European markets also dipped, while commodities like gold and silver fell. U.S. futures showed slight gains in early trading.

Portfolio Pulse from Akanksha Bakshi

February 01, 2024 | 12:08 pm